ClinicalTrials.Veeva

Menu

Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

N

Nestlé

Status

Enrolling

Conditions

Oncology
Cerebral Palsy (CP)

Treatments

Dietary Supplement: Tube feed

Study type

Interventional

Funder types

Industry

Identifiers

NCT07341464
IRAS ID 341165 (Other Identifier)
BTB 001

Details and patient eligibility

About

This is a prospective acceptability study to evaluate the gastrointestinal tolerance and compliance of a bolus tube feed over a 28 -day period for up to 50 participants.

The enteral bolus formula is for the dietary management of patients with short bowel syndrome; intractable malabsorption; preoperative preparation of undernourished patients; inflammatory bowel disease; total gastrectomy; dysphagia; bowel fistulae; feeding intolerances, developmental disabilities, and disease related malnutrition.

Full description

The study will collect data in 50 children and adults over a period of 28 days. Gastrointestinal tolerance will be collected over 7 days and formula intake will be over 28 days. A patient satisfaction questionnaire will be completed at the end of the study.

Enrollment

50 estimated patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients from 1 -15 years for children and 15 years and above for adults of requiring 1 or more bolus tube feed alongside their usual tube feed or home-made blended diet as part of their dietary management for disease related malnutrition.
  • Patients well-established and stable on current enteral tube feed or home-made blended diet.
  • Gastrostomy fed only.
  • Willingly given, written, informed consent from patient/caregiver

Exclusion criteria

  • Inability to comply with the study protocol, in the opinion of the investigator.
  • Under 1 years of age
  • Patients who have a nasogastric and jejunal feeding tubes
  • Patients on total parenteral nutrition
  • Known food allergies to any ingredients listed in appendix 1.
  • Patients with significant renal or hepatic impairment
  • Participation in another interventional study within 2 weeks of this study.
  • Patients with known or suspected ileus or mechanical bowel obstruction

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Acceptability and Tolerance Study of bolus tube feed with food blends
Other group
Description:
Arm one will act as their own controls
Treatment:
Dietary Supplement: Tube feed

Trial contacts and locations

2

Loading...

Central trial contact

Sarah Durnan, PHD, BSc Nutrition Dietetics; Sharan Saduera, BSc (Hons) Dietetics

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems